CIP2A and neoplasm: To further investigate the metastasis inhibitory effect of CIP2A-BP, injection of CIP2A-BP through the mammary pad significantly reduced the number of lung metastatic sites, as well as significantly reduced the p-AKT level of the primary tumor.